Regen BioPharma Inc (RGBP)

[cvinvestor]

ONPH is signing licensing deals left and right in 2021 without any cash. RGBP now depends on ONPH for income as it has licensed its most prominent research potential to ONPH.

At the end of 2020, ONPH had no cash. Ever think as to how ONPH will be able to put that science through Phase I,II and III clinical trials for approval of something before RGBP can ever get a dime back?

And ever consider how long that is going to take.

Koos has been sitting on the research and science for so long without it going anywhere that he hasn't even bothered to file paperwork for a one employee company with the SEC.

Now, because he is going to file the reports to become current, we are to believe everything is going to become a success? Hardly. The science may be sound and I had great hopes years ago, but it's going to take a solid company with deep pockets to get it to a useful product and right now ONPH has neither the pockets nor the track record.

This is a pure DT/Momentum play. A month from now this is more likely to be .006 than .06.


As for Koos, he already has his reward, 1.7 million in stock to sell at his leisure so he can pay himself in cash and more diluted shares for the future.
So new investors beware while new DT can try their hand.